Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease

Nature Medicine

Volumn 7, Issue 10, 2001, Pages 1144-1150

  Chung, Kenny K K ^a   Zhang, Yi ^a   Lim, Kah Leong ^a   Tanaka, Yuji ^a   Huang, Hui ^a   Gao, Jun ^a   Ross, Christopher A ^a   Dawson, Valina L ^a   Dawson, Ted M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GENE PRODUCT; PARKIN; SYNPHILIN 1; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EMBRYO; FAMILIAL DISEASE; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LEWY BODY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

ALPHA-SYNUCLEIN; ANIMALS; CARRIER PROTEINS; CELL LINE; GLYCOSYLATION; HUMANS; LEWY BODIES; LIGASES; MUTAGENESIS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RATS; SYNUCLEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 0034776095     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1001-1144     Document Type: Article

References (45)

1. Parkinson's disease. Second of two parts
2. Parkinson's disease. First of two parts
3. Pathology and biology of the Lewy body
4. Pathobiology of the Lewy body
5. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
6. Mutation in the α-synuclein gene identified in families with Parkinson's disease
7. α-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores
8. α-synuclein in Lewy bodies
9. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
10. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders
11. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
12. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
13. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
14. New animal models for Parkinson's disease
15. A Drosophila model of Parkinson's disease
16. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
17. Ubiquitin-mediated proteolysis: Biological regulation via destruction
18. Modes of regulation of ubiquitin-mediated protein degradation
19. The role of the ubiquitin proteasomal pathway in Parkinson's disease and other neurogenerative diseases
20. The ubiquitin pathway in Parkinson's disease
21. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
22. Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients
23. Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease
24. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle associated protein, CDCrel-1
25. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
26. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity
27. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin
28. Interaction of α-synuclein and synphilin-1: Effect of Parkinson's disease-associated mutations
29. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
30. Synphilin-1 is present in Lewy bodies in Parkinson's disease
31. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease
32. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
33. Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation
34. Dityrosine cross-linking promotes formation of stable α-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
35. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity
36. Oxidative stress and genetics in the pathogenesis of Parkinson's disease
37. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
38. α-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining
39. α-synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells
40. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism
41. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
42. Familial juvenile parkinsonism: Clinical and pathologic study in a family
43. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
44. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions